Project Grant HT94252510384
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$2.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
The University of California, Davis received a $598,340 project grant award from the Department of the Army Medical Command on September 1, 2022 to complete the project by August 31, 2025. The project aims to validate a multi-use scalable, long-acting nanoparticle anesthetic tilapia dressing for complex burn trauma under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to develop innovative medical solutions for Service Members and...
The University of California, Davis (UC Davis) was awarded a $644,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the university's research project "PLZ4-TARGETING ULTRA-SMALL DM1 NANOCONJUGATE FOR BLADDER CANCER THERAPY" with a performance period from June 1, 2025 to May 31, 2027. The project aims to develop and evaluate a novel targeted nanoconjugate therapy...
The University of California, Davis has been awarded a $1,298,836 Project Grant by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate the toxic products of combustion in burn and smoke inhalation injuries, a critical area of study for the...
The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
The federal Project Grant award of $321,981 was provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, this grant will enable the University of California, Davis to conduct research on "Sensory Processing Contributions to Emotion Dysregulation and...
The University of California, Davis (UC Davis) was awarded a $460,000.00 Project Grant from the Department of the Navy's Office of Naval Research (ONR) under the Basic and Applied Scientific Research (CFDA 12.300) federal grant program. The award, with a performance period from May 1, 2024 to April 30, 2027, will support research on "Dynamic Cortico-Hippocampal Interactions for Flexible Goal-Driven Agents." This grant-funded project aims to advance scientific understanding and...
The University of California, Davis was awarded a $483,000 Project Grant from the Department of the Army's Military Medical Research and Development program (CFDA 12.420) to conduct research on "TARGETING DRUG-TOLERANT PERSISTER CELLS IN OVARIAN CANCER." The award period is from April 1, 2024 to March 31, 2026. The objective of this research project is to develop new treatments for ovarian cancer by targeting drug-tolerant persister cells. As a major public research university, UC...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...
The University of California, Davis was awarded a $1,446,009 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to target CD200/CD200R signaling as a novel strategy for treating therapy-resistant prostate cancer. The grant, awarded July 1, 2023 and set to be completed by June 30, 2026, will support research into medical solutions for prostate cancer that remains unresponsive to standard treatments by...